Furthermore, scRNA‐seq revealed the cellular origins and evolutionary patterns of breast cancer in BRCA1 mutation carriers, identifying potential therapeutic targets for patients with BRCA1 mutations [103]. Here, BRCA1 is linked to breast carcinoma.